Cargando…

Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment

Same clinical entity can have different biology and can behave differently. This must be kept in mind while making therapeutic decisions. Primary effusion lymphoma is a rare and devastating disease with high fatality. Chemotherapy provides limited benefit. We describe a unique case of a good outcome...

Descripción completa

Detalles Bibliográficos
Autores principales: Koren, Ofir, Aviv, Ariel, Kelbert, Moran Avraham, Rozner, Ehud, Lihtman, Liza, Halfin, Elya, Turgeman, Yoav
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077339/
https://www.ncbi.nlm.nih.gov/pubmed/33936684
http://dx.doi.org/10.1002/ccr3.4020
_version_ 1783684864206176256
author Koren, Ofir
Aviv, Ariel
Kelbert, Moran Avraham
Rozner, Ehud
Lihtman, Liza
Halfin, Elya
Turgeman, Yoav
author_facet Koren, Ofir
Aviv, Ariel
Kelbert, Moran Avraham
Rozner, Ehud
Lihtman, Liza
Halfin, Elya
Turgeman, Yoav
author_sort Koren, Ofir
collection PubMed
description Same clinical entity can have different biology and can behave differently. This must be kept in mind while making therapeutic decisions. Primary effusion lymphoma is a rare and devastating disease with high fatality. Chemotherapy provides limited benefit. We describe a unique case of a good outcome with steroid alone treatment.
format Online
Article
Text
id pubmed-8077339
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80773392021-04-29 Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment Koren, Ofir Aviv, Ariel Kelbert, Moran Avraham Rozner, Ehud Lihtman, Liza Halfin, Elya Turgeman, Yoav Clin Case Rep Case Reports Same clinical entity can have different biology and can behave differently. This must be kept in mind while making therapeutic decisions. Primary effusion lymphoma is a rare and devastating disease with high fatality. Chemotherapy provides limited benefit. We describe a unique case of a good outcome with steroid alone treatment. John Wiley and Sons Inc. 2021-03-04 /pmc/articles/PMC8077339/ /pubmed/33936684 http://dx.doi.org/10.1002/ccr3.4020 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Reports
Koren, Ofir
Aviv, Ariel
Kelbert, Moran Avraham
Rozner, Ehud
Lihtman, Liza
Halfin, Elya
Turgeman, Yoav
Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
title Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
title_full Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
title_fullStr Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
title_full_unstemmed Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
title_short Primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
title_sort primary effusion lymphoma in a patient with a good outcome on steroid alone treatment
topic Case Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8077339/
https://www.ncbi.nlm.nih.gov/pubmed/33936684
http://dx.doi.org/10.1002/ccr3.4020
work_keys_str_mv AT korenofir primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment
AT avivariel primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment
AT kelbertmoranavraham primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment
AT roznerehud primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment
AT lihtmanliza primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment
AT halfinelya primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment
AT turgemanyoav primaryeffusionlymphomainapatientwithagoodoutcomeonsteroidalonetreatment